α-synuclein promotes mitochondrial deficit and oxidative stress

American Journal of Pathology

Volumn 157, Issue 2, 2000, Pages 401-410

  Hsu, Leigh J ^a,b   Sagara, Yutaka ^b   Arroyo, Armando ^a   Rockenstein, Edward ^b   Sisk, Abbyann ^b   Mallory, Margaret ^b   Wong, Jeff ^a   Takenouchi, Takato ^b   Hashimoto, Makoto ^b   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ALPHA TOCOPHEROL; ANTIOXIDANT; FREE RADICAL; GONADORELIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HORMONE RELEASE; HYPOTHALAMUS; MOUSE; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033890821     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64553-1     Document Type: Article

References (54)

1. Synuciein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
2. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
3. Identification of two distinct synucleins from human brain
4. The rat brain synucleins; family of proteins transiently associated with neuronal membrane
5. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
6. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for pnospnorylation
7. Organization, expression and polymorphism of the human persyn gene
8. Genomic structure and chromosomal localization of the mouse persyn gene
9. Synoretin-A new protein belonging to the synuclein family
10. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
11. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
12. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
13. Lewy body diseases and multiple system atrophy as alpha-synucleinopathies
14. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease
15. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
16. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders
17. Aggregation of neurofilament and alphasynuclein proteins in Lewy bodies: Implications for the pathogenesis of Parkinson disease and Lewy body dementia
18. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neuro-degenerative disorders
19. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments
20. A Drosophila model of Parkinson's disease
21. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
22. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
23. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
24. Point mutations of mitochondrial genome in Parkinson's disease
25. Origin and functional consequences of the complex l defect in Parkinson's disease
26. Quantitative study of mitochondrial complex l in platelets of parkinsonian patients
27. Mitochondrial dysfunction in Parkinson's disease
28. Mitochondria in the etiology and pathogenesis of Parkinson's disease
29. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis
30. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development
31. Levels and alternative splicing of amyloid β-protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease
32. The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system
33. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia
34. Protein measurement with Folin phenol reagent
35. Aberrant Presenilin-1 expression downregulates LDL receptor-related protein (LRP): Is LRP central to Alzheimer's disease pathogenesis?
36. Nitric oxide is involved in the genesis of pulsatile LHRH secretion from immortalized LHRH neurons
37. Induction of reactive oxygen species in neurons by haloperidol
38. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species
39. Apoptosis in neurodegeneration diseases: The role of mitochondria
40. α-Synuclein shares physical and functional homology with 14-3-3 proteins
41. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
42. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease
43. N-ethylmaleimide-sensitive fusion protein: A trimeric ATPase whose hydrolysis of ATP is required for membrane fusion
44. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes
45. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins
46. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization
47. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: Relevance to Parkinson's disease
48. Understanding cell death in Parkinson's disease
49. Deficiencies of the respiratory chain in Parkinson's disease
50. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
51. Mitochondrial complex l deficiency in Parkinson's disease
52. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
53. Brain, skeletal muscle, and platelet homogenate mitochondrial functions in Parkinson's disease
54. Mechanisms of the neurotoxicity of MPTP